FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention

被引:92
作者
De Luca, Antonella [1 ]
Esposito Abate, Riziero [1 ]
Rachiglio, Anna Maria [1 ]
Maiello, Monica Rosaria [1 ]
Esposito, Claudia [1 ]
Schettino, Clorinda [2 ]
Izzo, Francesco [3 ]
Nasti, Guglielmo [4 ]
Normanno, Nicola [1 ]
机构
[1] Ist Nazl Tumori IRCCS Fdn G Pascale, Cell Biol & Biotherapy Unit, I-80131 Naples, Italy
[2] Ist Nazl Tumori IRCCS Fdn G Pascale, Clin Trials Unit, I-80131 Naples, Italy
[3] Ist Nazl Tumori IRCCS Fdn G Pascale, Hepatobiliary Unit, Div Surg Oncol, I-80131 Naples, Italy
[4] Ist Nazl Tumori IRCCS Fdn G Pascale, SSD Innovat Therapies Abdominal Canc, I-80131 Naples, Italy
关键词
fibroblast growth factor receptors; FGFR fusions; next generation sequencing; cancer; FGFR inhibitors; GROWTH-FACTOR RECEPTOR; UNIQUE MOLECULAR SUBTYPE; GENE FUSIONS; UROTHELIAL CARCINOMA; TARGETED THERAPY; OPEN-LABEL; PHASE-II; IDENTIFICATION; MUTATIONS; CHOLANGIOCARCINOMA;
D O I
10.3390/ijms21186856
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast growth factor receptors (FGFRs) are tyrosine kinase receptors involved in many biological processes. Deregulated FGFR signaling plays an important role in tumor development and progression in different cancer types.FGFRgenomic alterations, includingFGFRgene fusions that originate by chromosomal rearrangements, represent a promising therapeutic target. Next-generation-sequencing (NGS) approaches have significantly improved the discovery ofFGFRgene fusions and their detection in clinical samples. A variety of FGFR inhibitors have been developed, and several studies are trying to evaluate the efficacy of these agents in molecularly selected patients carryingFGFRgenomic alterations. In this review, we describe the most frequentFGFRaberrations in human cancer. We also discuss the different approaches employed for the detection ofFGFRfusions and the potential role of these genomic alterations as prognostic/predictive biomarkers.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 71 条
[61]   Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models [J].
Taylor, James G. ;
Cheuk, Adam T. ;
Tsang, Patricia S. ;
Chung, Joon-Yong ;
Song, Young K. ;
Desai, Krupa ;
Yu, Yanlin ;
Chen, Qing-Rong ;
Shah, Kushal ;
Youngblood, Victoria ;
Fang, Jun ;
Kim, Su Young ;
Yeung, Choh ;
Helman, Lee J. ;
Mendoza, Arnulfo ;
Ngo, Vu ;
Staudt, Louis M. ;
Wei, Jun S. ;
Khanna, Chand ;
Catchpoole, Daniel ;
Qualman, Stephen J. ;
Hewitt, Stephen M. ;
Merlino, Glenn ;
Chanock, Stephen J. ;
Khan, Javed .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (11) :3395-3407
[62]   Knockdown by shRNA identifes S249C mutant FGFR3 as a potential therapeutic target in bladder cancer [J].
Tomlinson, D. C. ;
Hurst, C. D. ;
Knowles, M. A. .
ONCOGENE, 2007, 26 (40) :5889-5899
[63]   Biology of FGFRL1, the fifth fibroblast growth factor receptor [J].
Trueb, Beat .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (06) :951-964
[64]   FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non-Small Cell Lung Cancer [J].
Wang, Rui ;
Wang, Lei ;
Li, Yuan ;
Hu, Haichuan ;
Shen, Lei ;
Shen, Xuxia ;
Pan, Yunjian ;
Ye, Ting ;
Zhang, Yang ;
Luo, Xiaoyang ;
Zhang, Yiliang ;
Pan, Bin ;
Li, Bin ;
Li, Hang ;
Zhang, Jie ;
Pao, William ;
Ji, Hongbin ;
Sun, Yihua ;
Chen, Haiquan .
CLINICAL CANCER RESEARCH, 2014, 20 (15) :4107-4114
[65]   Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein [J].
Wang, Yu ;
Ding, Xiwei ;
Wang, Shaoqing ;
Moser, Catherine D. ;
Shaleh, Hassan M. ;
Mohamed, Essa A. ;
Chaiteerakij, Roongruedee ;
Allotey, Loretta K. ;
Chen, Gang ;
Miyabe, Katsuyuki ;
McNulty, Melissa S. ;
Ndzengue, Albert ;
Fritcher, Emily G. Barr ;
Knudson, Ryan A. ;
Greipp, Patricia T. ;
Clark, Karl J. ;
Torbenson, Michael S. ;
Kipp, Benjamin R. ;
Zhou, Jie ;
Barrett, Michael T. ;
Gustafson, Michael P. ;
Alberts, Steven R. ;
Borad, Mitesh J. ;
Roberts, Lewis R. .
CANCER LETTERS, 2016, 380 (01) :163-173
[66]   Oncogenic FGFR3 gene fusions in bladder cancer [J].
Williams, Sarah V. ;
Hurst, Carolyn D. ;
Knowles, Margaret A. .
HUMAN MOLECULAR GENETICS, 2013, 22 (04) :795-803
[67]   Identification of Targetable FGFR Gene Fusions in Diverse Cancers [J].
Wu, Yi-Mi ;
Su, Fengyun ;
Kalyana-Sundaram, Shanker ;
Khazanov, Nickolay ;
Ateeq, Bushra ;
Cao, Xuhong ;
Lonigro, Robert J. ;
Vats, Pankaj ;
Wang, Rui ;
Lin, Su-Fang ;
Cheng, Ann-Joy ;
Kunju, Lakshmi P. ;
Siddiqui, Javed ;
Tomlins, Scott A. ;
Wyngaard, Peter ;
Sadis, Seth ;
Roychowdhury, Sameek ;
Hussain, Maha H. ;
Feng, Felix Y. ;
Zalupski, Mark M. ;
Talpaz, Moshe ;
Pienta, Kenneth J. ;
Rhodes, Daniel R. ;
Robinson, Dan R. ;
Chinnaiyan, Arul M. .
CANCER DISCOVERY, 2013, 3 (06) :636-647
[68]   Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing [J].
Yang, Lixing ;
Lee, Mi-Sook ;
Lu, Hengyu ;
Oh, Doo-Yi ;
Kim, Yeon Jeong ;
Park, Donghyun ;
Park, Gahee ;
Ren, Xiaojia ;
Bristow, Christopher A. ;
Haseley, Psalm S. ;
Lee, Soohyun ;
Pantazi, Angeliki ;
Kucherlapati, Raju ;
Park, Woong-Yang ;
Scott, Kenneth L. ;
Choi, Yoon-La ;
Park, Peter J. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 98 (05) :843-856
[69]   The landscape and therapeutic relevance of cancer-associated transcript fusions [J].
Yoshihara, K. ;
Wang, Q. ;
Torres-Garcia, W. ;
Zheng, S. ;
Vegesna, R. ;
Kim, H. ;
Verhaak, R. G. W. .
ONCOGENE, 2015, 34 (37) :4845-4854
[70]   Anchored multiplex FOR for targeted next-generation sequencing [J].
Zheng, Zongli ;
Liebers, Matthew ;
Zhelyazkova, Boryana ;
Cao, Yi ;
Panditi, Divya ;
Lynch, Kerry D. ;
Chen, Juxiang ;
Robinson, Hayley E. ;
Shim, Hyo Sup ;
Chmielecki, Juliann ;
Pao, William ;
Engelman, Jeffrey A. ;
Iafrate, A. John ;
Le, Long Phi .
NATURE MEDICINE, 2014, 20 (12) :1479-1484